EMA Clarifies GMP Responsibilities for Marketing Authorization Holders

The European Medicines Agency issued a draft paper to clarify the responsibilities of marketing authorization holders (MAHs) under the EU’s GMP regulations, which the EMA conceded can be confusing.
Source: Drug Industry Daily